The latest trading session saw Gilead Sciences (GILD) ending at $85.39, denoting a +1.05% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a loss of 0.07% for the day. Shares of the HIV and hepatitis C drugmaker witnessed a gain of 1.7% over the previous month, trailing the performance of the Medical sector with its gain of 7.37% and the S&P 500's gain of 3.98%. Investors will be eagerly watching for the performance of Gilead Sciences in its upcoming earnings disclosure ...